Log In
Print this Print this

mesalazine (TP05)

  Manage Alerts
Collapse Summary General Information
Company Zeria Pharmaceutical Co. Ltd.
DescriptionOpticore formulation of mesalazine
Molecular Target
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase III
Standard IndicationInflammatory bowel disease (IBD)
Indication DetailsTreat acute ulcerative colitis (UC)
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today